Clinical Trial Update: Study of ODX (Osteodex) in Metastatic Castration Resistant Prostate Cancer (CRPC) [Phase 2]

View source ↗

Summary

Phase 2 study of ODX (Osteodex) in metastatic castration-resistant prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• ODX (Osteodex)

Snippet

Sponsor: DexTech Medical AB | Conditions: Prostate Cancer Metastatic | Phase 2 | Status: COMPLETED